Click a link below to view the mailing archive as if it had been sent to you.
| 2024-12-31 00:15 | | FDA approves BMS’ Opdivo Qvantig for solid tumour indications and more... |
| 2024-12-20 12:15 | | Novo’s next-gen obesity drug misses expectations in closely watched trial and more... |
| 2024-12-20 00:15 | | Zepbound, Mounjaro shortages are resolved, FDA confirms and more... |
| 2024-12-19 12:15 | | Regeneron anticoagulant bests enoxaparin, matches Eliquis in phase 2 trial and more... |
| 2024-12-19 00:15 | | Bird flu update: California declares emergency and U.S. sees 1st severe human case and more... |
| 2024-12-18 12:15 | | Pfizer CEO says he developed 'good relation' with RFK Jr., highlights Trump's pride in vaccine work and more... |
| 2024-12-18 00:15 | | FDA grants fast-track status to combination mRNA flu and COVID-19 vaccine candidates and more... |
| 2024-12-17 12:15 | | Sanofi, Teva say study results show gut disease drug could be ‘best in class’ and more... |
| 2024-12-17 00:15 | | BMS’ Cost-Cutting Campaign Claims Collabs With Immatics, Century and more... |
| 2024-12-16 12:15 | | Novo Nordisk blueprints $1.2B rare disease production plant in Denmark, where it plans to hire on 400 new staffers and more... |
| 2024-12-16 00:15 | | Regulatory conditions on Novo Holdings' $16.5 billion Catalent deal fulfilled, companies say and more... |
| 2024-12-13 12:15 | | AbbVie to acquire Roche spinout Nimble in immune drug deal and more... |
| 2024-12-13 00:15 | | Editas to lay off staff after search for sickle cell partner comes up empty and more... |
| 2024-12-12 12:15 | | Industry M&A volume declined 8% this year compared to '23 and more... |
| 2024-12-12 00:15 | | Bavarian Nordic plans to shut down San Diego R&D site, lay off 48 employees and more... |
| 2024-12-11 12:15 | | With Biktarvy patent cliff ahead, Gilead lays out a plan to keep the HIV crown with 7 launches through 2033 and more... |
| 2024-12-11 00:15 | | NewAmsterdam drug shows ‘unexpected’ signs of protecting the heart in latest study and more... |
| 2024-12-10 12:15 | | BioNTech's overall survival data show promise of potential Keytruda killer in breast cancer and more... |
| 2024-12-10 00:15 | | ASH: With survival win against J&J's Darzalex, GSK bolsters case for return of myeloma ADC Blenrep and more... |
| 2024-12-09 12:15 | | ASH 2024: AstraZeneca set to take a BiTE out of follicular lymphoma market and more... |
| 2024-12-09 00:15 | | Trump, RFK Jr. dine with Pfizer and Lilly execs and more... |
| 2024-12-06 12:15 | | FDA outlines accelerated review guidelines in waning days of Biden administration and more... |
| 2024-12-06 00:15 | | On an investment spree, Lilly will spend $3B to expand newly acquired injectables plant in Wisconsin and more... |
| 2024-12-05 12:15 | | GSK inks 2nd neuro pact in weeks, this time with Danish biotech Muna in Alzheimer's and more... |
| 2024-12-05 00:15 | | Antag, a startup backed by Versant and Novo, joins hunt for obesity drug alternatives and more... |
| 2024-12-04 12:15 | | Novavax to sell Czech manufacturing unit to Novo Nordisk for $200 million and more... |
| 2024-12-04 00:15 | | Janux impresses Wall Street with new prostate cancer drug results and more... |
| 2024-12-03 12:15 | | Novo Nordisk India execs urge early Wegovy launch as weight-loss rival looms and more... |
| 2024-12-03 00:15 | | FDA considers 'regulatory action' for bluebird's Skysona after blood cancer reports and more... |
| 2024-12-02 12:15 | | Novartis wagers billions of dollars on PTC Huntington’s drug and more... |
| 2024-12-01 12:15 | | Neuralink reports green light to study brain-controlled robotic arms and more... |
